I V B Medical Supply Inc is categorized under Medical Examinations-Insurance in Brooklyn, NY and active since 2000.
I V B Medical Supply Inc was established in 2000, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Medical Examinations-Insurance business, which does work in the B2C market, and is classified as a Medical Examinations-Insurance, under code number 621999 by the NAICS.
If you are seeking more information, feel free to contact Igor Berlovich at the company’s single location by writing to 1824 Gravesend Neck Road, Brooklyn, New York NY 11229 or by phoning (718) 769-5000. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | I V B Medical Supply Inc |
| Contact Person: | Igor Berlovich |
| Address: | 1824 Gravesend Neck Road, Brooklyn, New York 11229 |
| Phone Number: | (718) 769-5000 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2000 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Medical Examinations-Insurance |
| SIC Code: | 8099 |
| NAICS Code: | 621999 |
| Share This Business: |
I V B Medical Supply Inc was started in 2000 to provide professional Medical Examinations-Insurance under the SIC code 8099 and NAICS code 621999. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Igor Berlovich for inquiries that concern I V B Medical Supply Inc by calling the company number (718) 769-5000, as your correspondence is most welcome. Additionally, the physical location of the single location of I V B Medical Supply Inc can be found at the coordinates 40.595831,-73.95237 as well as the street address 1824 Gravesend Neck Road in Brooklyn, New York 11229.
For its online presence, you may visit I V B Medical Supply Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.